Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis.


Journal

Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 19 01 2021
accepted: 18 03 2021
pubmed: 29 4 2021
medline: 18 9 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) disrupts routine care and alters treatment pathways in every medical specialty, including intensive care medicine, which has been at the core of the pandemic response. The impact of the pandemic is inevitably not limited to patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their outcomes; however, the impact of COVID-19 on intensive care has not yet been analyzed. The objective of this propensity score-matched study was to compare the clinical outcomes of non-COVID-19 critically ill patients with the outcomes of prepandemic patients. Critically ill, non-COVID-19 patients admitted to the intensive care unit (ICU) during the first wave of the pandemic were matched with patients admitted in the previous year. Mortality, length of stay, and rate of readmission were compared between the two groups after matching. A total of 211 critically ill SARS-CoV‑2 negative patients admitted between 13 March 2020 and 16 May 2020 were matched to 211 controls, selected from a matching pool of 1421 eligible patients admitted to the ICU in 2019. After matching, the outcomes were not significantly different between the two groups: ICU mortality was 5.2% in 2019 and 8.5% in 2020, p = 0.248, while intrahospital mortality was 10.9% in 2019 and 14.2% in 2020, p = 0.378. The median ICU length of stay was similar in 2019: 4 days (IQR 2-6) compared to 2020: 4 days (IQR 2-7), p = 0.196. The rate of ICU readmission was 15.6% in 2019 and 10.9% in 2020, p = 0.344. In this retrospective single center study, mortality, ICU length of stay, and rate of ICU readmission did not differ significantly between patients admitted to the ICU during the implementation of hospital-wide COVID-19 contingency planning and patients admitted to the ICU before the pandemic.

Sections du résumé

BACKGROUND BACKGROUND
Coronavirus disease 2019 (COVID-19) disrupts routine care and alters treatment pathways in every medical specialty, including intensive care medicine, which has been at the core of the pandemic response. The impact of the pandemic is inevitably not limited to patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their outcomes; however, the impact of COVID-19 on intensive care has not yet been analyzed.
METHODS METHODS
The objective of this propensity score-matched study was to compare the clinical outcomes of non-COVID-19 critically ill patients with the outcomes of prepandemic patients. Critically ill, non-COVID-19 patients admitted to the intensive care unit (ICU) during the first wave of the pandemic were matched with patients admitted in the previous year. Mortality, length of stay, and rate of readmission were compared between the two groups after matching.
RESULTS RESULTS
A total of 211 critically ill SARS-CoV‑2 negative patients admitted between 13 March 2020 and 16 May 2020 were matched to 211 controls, selected from a matching pool of 1421 eligible patients admitted to the ICU in 2019. After matching, the outcomes were not significantly different between the two groups: ICU mortality was 5.2% in 2019 and 8.5% in 2020, p = 0.248, while intrahospital mortality was 10.9% in 2019 and 14.2% in 2020, p = 0.378. The median ICU length of stay was similar in 2019: 4 days (IQR 2-6) compared to 2020: 4 days (IQR 2-7), p = 0.196. The rate of ICU readmission was 15.6% in 2019 and 10.9% in 2020, p = 0.344.
CONCLUSION CONCLUSIONS
In this retrospective single center study, mortality, ICU length of stay, and rate of ICU readmission did not differ significantly between patients admitted to the ICU during the implementation of hospital-wide COVID-19 contingency planning and patients admitted to the ICU before the pandemic.

Identifiants

pubmed: 33909109
doi: 10.1007/s00508-021-01857-4
pii: 10.1007/s00508-021-01857-4
pmc: PMC8080479
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

942-950

Informations de copyright

© 2021. The Author(s).

Références

N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Crit Care. 2020 Jun 30;24(1):386
pubmed: 32605581
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
PLoS One. 2020 Sep 24;15(9):e0239801
pubmed: 32970774
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Intensive Care Med. 2020 Jul;46(7):1303-1325
pubmed: 32514598
Crit Care. 2020 Apr 28;24(1):176
pubmed: 32345343
J Infect. 2020 Nov;81(5):797-801
pubmed: 32956730
Crit Care. 2020 Mar 31;24(1):124
pubmed: 32234064
Crit Care Med. 2020 Jun;48(6):e440-e469
pubmed: 32224769
N Engl J Med. 2004 Oct 28;351(18):1838-48
pubmed: 15509817
Arch Dis Child. 2020 Jul;105(7):704-706
pubmed: 32461213
Stroke Vasc Neurol. 2020 Dec;5(4):403-405
pubmed: 32855352
Nat Med. 2020 Dec;26(12):1919-1928
pubmed: 33057181
Can J Surg. 2020 May 1;63(22):S2-S4
pubmed: 32343118
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265003
JAMA. 2019 Jul 16;322(3):216-228
pubmed: 31310297
Crit Care Med. 2018 Mar;46(3):347-353
pubmed: 29474319
Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):210-216
pubmed: 32467968
Stat Med. 2014 Mar 15;33(6):1057-69
pubmed: 24123228
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Heart. 2020 Dec;106(23):1805-1811
pubmed: 32868280
N Engl J Med. 2020 Aug 13;383(7):691-693
pubmed: 32427432
ERJ Open Res. 2020 Sep 28;6(3):
pubmed: 33015145
Can J Anaesth. 2020 Oct;67(10):1405-1416
pubmed: 32458267
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Intensive Care Med. 2009 Apr;35(4):616-22
pubmed: 18846365
PLoS One. 2020 Jul 10;15(7):e0235653
pubmed: 32649661
Ann Vasc Surg. 2020 Nov;69:100-104
pubmed: 32791192
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Nat Cancer. 2020 Jun;1(6):565-567
pubmed: 35121972
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131

Auteurs

Răzvan Bologheanu (R)

Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Vienna, Austria. razvan.bologheanu@meduniwien.ac.at.

Mathias Maleczek (M)

Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Vienna, Austria.

Daniel Laxar (D)

Ludwig Boltzmann Institute for Digital Health and Patient Safety, Vienna, Austria.

Oliver Kimberger (O)

Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH